93 related articles for article (PubMed ID: 11780577)
1. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
2. [The activity of cathepsin B in colorectal adenocarcinomas].
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Sulkowski S; Chrzanowska A
Pol Merkur Lekarski; 2001 Oct; 11(64):330-3. PubMed ID: 11770313
[TBL] [Abstract][Full Text] [Related]
3. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
6. [Cathepsin D activity in gastric cancer].
Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
8. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
[TBL] [Abstract][Full Text] [Related]
9. [Activity of cathepsin D in some neoplasms of the gastrointestinal tract].
Kiluk M; Skrzydlewski Z; Kiluk A; Woroniecki A; Rucińska M; Kozłowski L
Pol Merkur Lekarski; 1997 May; 2(11):307-8. PubMed ID: 9377676
[TBL] [Abstract][Full Text] [Related]
10. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
Gassler N; Herr I; Schneider A; Penzel R; Langbein L; Schirmacher P; Kopitz J
J Pathol; 2005 Nov; 207(3):295-300. PubMed ID: 16110457
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
12. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.
Linder N; Martelin E; Lundin M; Louhimo J; Nordling S; Haglund C; Lundin J
Eur J Cancer; 2009 Mar; 45(4):648-55. PubMed ID: 19112016
[TBL] [Abstract][Full Text] [Related]
13. Activity of cathepsin D and alpha(1)-antitrypsin in the blood serum of patients with mammary carcinoma.
Wozniak A; Mila-Kierzenkowska C; Schachtschabel DO; Wozniak B; Rozwodowska M; Drewa T; Drewa S; Sir J; Sir I; Maciak R; Krzyzynska-Malinowska E
Exp Oncol; 2005 Sep; 27(3):233-7. PubMed ID: 16244588
[TBL] [Abstract][Full Text] [Related]
14. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
[TBL] [Abstract][Full Text] [Related]
15. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Guzińska-Ustymowicz K
Anticancer Res; 2006; 26(2B):1589-94. PubMed ID: 16619576
[TBL] [Abstract][Full Text] [Related]
16. Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer.
Di Marzio L; Di Leo A; Cinque B; Fanini D; Agnifili A; Berloco P; Linsalata M; Lorusso D; Barone M; De Simone C; Cifone MG
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):856-62. PubMed ID: 15824156
[TBL] [Abstract][Full Text] [Related]
17. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
[TBL] [Abstract][Full Text] [Related]
18. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer.
Manuel Del Casar J; Vizoso FJ; Abdel-Laa O; Sanz L; Martín A; Daniela Corte M; Bongera M; García Muñiz JL; Fueyo A
J Surg Oncol; 2004 Apr; 86(1):16-21. PubMed ID: 15048675
[TBL] [Abstract][Full Text] [Related]
20. Reduced nonspecific steroidal esterase activity in human malignant tumor tissue from liver, colon and breast when compared to peritumoral and normal tissue levels.
Lund-Pero M; Jeppson B; Pero RW
Anticancer Res; 1994; 14(6B):2747-53. PubMed ID: 7872712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
